DSP Nifty Healthcare Index Fund Regular-Growth
Large CapEquity: Sectoral-Pharmaअतिशय जास्त जोखीम
PaisaSmart रेटिंग★★★★★0
हे रेटिंग का
This index fund/ETF has a beta of nan%, and an expense ratio of 1.08%, giving it a 0.0 star rating, based on the principle that lower values of |1-beta| and expense ratio result in higher ratings.
आमचा स्कोअर दीर्घकालीन कामगिरी, जोखीम आणि सातत्य यांचे वजन करतो — फक्त मागील परतावे नाही.
परतावा
8 Oct 2026 पर्यंत
1W
-2.57%
1M
-5.73%
3M
-2.87%
6M
+11.24%
9M
+5.74%
1Y
+8.17%
सुरुवातीपासून
+8.09%
पोर्टफोलिओ
31 Aug 2026 पर्यंत
मार्केट-कॅप विभागणी
लार्ज कॅप49.53%मिड कॅप48.66%स्मॉल कॅप1.81%
P/E
37.68
P/B
4.90
शैली
Growth
क्षेत्रनिहाय वाटप
Healthcare99.98%
होल्डिंग्स (21)
| होल्डिंग | फंडाचा % | मूल्य | शेअर्स |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 18.08% | ₹4.59 Cr | 23,144 |
| Divi's Laboratories Ltd. | 10.35% | ₹2.63 Cr | 2,777 |
| Apollo Hospitals Enterprise Ltd. | 7.88% | ₹2 Cr | 2,249 |
| Cipla Ltd. | 6.82% | ₹1.73 Cr | 12,299 |
| Max Healthcare Institute Ltd. | 6.67% | ₹1.7 Cr | 16,267 |
| Laurus Labs Ltd. | 6.41% | ₹1.63 Cr | 8,504 |
| Torrent Pharmaceuticals Ltd. | 6.39% | ₹1.62 Cr | 3,206 |
| Dr. Reddy's Laboratories Ltd. | 6.05% | ₹1.54 Cr | 13,324 |
| Lupin Ltd. | 4.57% | ₹1.16 Cr | 5,308 |
| Aurobindo Pharma Ltd. | 4.09% | ₹1.04 Cr | 6,050 |
फंड तपशील
थोडक्यात
Long-term capital growth. Investment in equity and equity related securities covered by Nifty Healthcare Index, subject to tracking error.
गुंतवणूक उद्दिष्ट
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
फंड प्रकार
Open-ended
किमान एकरकमी
₹100
किमान काढणी
₹100
लॉक-इन
नाही
SIP
उपलब्ध
SWP
उपलब्ध
STP
उपलब्ध
खरेदी कट-ऑफ
15:00